SCHEMBL2029476

SCHEMBL2029476

O=C(O)NC(c1ccccc1)[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GSR P00390 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SRC P12931 1/20 0.39
LMNA P02545 3/20 0.39
CTRB1 P17538 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27524142 0.85 ALDH1A1 (0.50) GSRL3MBTL1TDP1HTTSMN1; SMN2
SCHEMBL516296 0.81 TGM2 (0.43) MEN1KMT2ACYP2C9CYP2C19L3MBTL1
SCHEMBL8951918 0.81 ATM (0.46) MAPTMEN1KMT2ACYP2C19L3MBTL1
SCHEMBL6129084 0.80 GSR (0.42) MEN1KMT2ACYP2D6GSRTDP1
Hydrochloric Acid SCHEMBL21219507 0.78 GSR (0.41) MEN1KMT2ACYP2D6GSRTDP1
SCHEMBL26697095 0.77 CTSK (0.50) MAPTTDP1
SCHEMBL8930553 0.77 GSR (0.40) MAPTMEN1KMT2ACYP2C19GSR
SCHEMBL7058262 0.76 KDM4E (0.52) KMT2AL3MBTL1TDP1HTTSMN1; SMN2
SCHEMBL27394315 0.76 HTR2A (0.39) MAPTMEN1KMT2ACYP2D6CYP2C9
SCHEMBL2325620 0.76 AOC3 (0.39) MAPTMEN1KMT2ANPSR1GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4343326-B1 BIOLOGICAL CONJUGATES HAVING AN PHOTOGENERATED ACIDIC OR BASIC RELEASABLE DETECTION MOIETY ON TOP OF BIOLOGICAL TISSUES MILTENYI BIOTEC BV & CO KG (DE) 2025-03-12 EP claimed
EP-4343326-A1 BIOLOGICAL CONJUGATES HAVING AN PHOTOGENERATED ACIDIC OR BASIC RELEASABLE DETECTION MOIETY ON TOP OF BIOLOGICAL TISSUES Miltenyi Biotec B.V. & Co. KG (DE) 2024-03-27 EP claimed
US-20240094198-A1 BIOLOGICAL CONJUGATES HAVING AN PHOTOGENERATED ACIDIC OR BASIC RELEASABLE DETECTION MOIETY ON TOP OF BIOLOGICAL TISSUES Miltenyi Biotec B.V. & Co. KG (DE) 2024-03-21 US claimed
US-9102704-B2 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines SPIROGEN SARL (CH) 2015-08-11 US claimed
US-20140275522-A1 SYNTHESIS METHOD AND INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLOBENZODIAZEPINES SPIROGEN SÁRL (CH) 2014-09-18 US claimed
EP-1119529-B1 CHEMICAL CONSTRUCTS GLAXO GROUP LTD (GB) 2003-09-17 EP claimed
JP-2002526512-A 2002-08-20 JP claimed
EP-1119529-A2 CHEMICAL CONSTRUCTS GLAXO GROUP LIMITED (GB) 2001-08-01 EP claimed
WO-2000020357-A2 CHEMICAL CONSTRUCTS GLAXO GROUP LIMITED (GB) 2000-04-13 WO claimed
WO-2026100508-A1 RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, SEMICONDUCTOR DEVICE, AND RESIN 富士フイルム株式会社 2026-05-15 WO disclosed
US-20260003276-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2026-01-01 US disclosed
US-20260003281-A1 RESIN COMPOSITION, DIAMINE COMPOUND, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2026-01-01 US disclosed
US-20260003274-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJIFILM CORP (JP) 2026-01-01 US disclosed
US-20250376552-A1 RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE FUJIFILM CORP (JP) 2025-12-11 US disclosed
US-6106999-A SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS MITSUI CHEMICALS (JP) 2000-08-22 US disclosed
WO-2000020357-A2 CHEMICAL CONSTRUCTS GLAXO GROUP LIMITED (GB) 2000-04-13 WO disclosed
WO-2000017397-A1 SEQUENCING DUPLEX DNA BY MASS SPECTROSCOPY BIOTRACES, INC. (US) 2000-03-30 WO disclosed
EP-0622682-B1 Photosensitive resin composition HITACHI CHEMICAL CO LTD (JP) 1998-03-04 EP disclosed
EP-0119895-B1 1,2-DITHIOL-3-ONE DERIVATIVES, THEIR PREPARATION AND MEDICINAL COMPOSITIONS CONTAINING THEM RHONE-POULENC SANTE (FR) 1987-01-28 EP disclosed
EP-0119895-A1 1,2-Dithiol-3-one derivatives, their preparation and medicinal compositions containing them RHONE-POULENC SANTE (FR) 1984-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260003281-A1 RESIN COMPOSITION, DIAMINE COMPOUND, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE SEM1, SAT1, ASIC1 MAPT 827/4885MEN1 2485/4885KMT2A 681/4885
US-20140275522-A1 SYNTHESIS METHOD AND INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLOBENZODIAZEPINES ORC3, OXER1, SCO2 MAPT 4429/4885MEN1 2359/4885KMT2A 2003/4885
US-20260003274-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE SEM1, ASIC1, SMARCB1 MAPT 331/4885MEN1 1997/4885KMT2A 887/4885
US-20260003276-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE RER1, SEM1, RAD51 MAPT 2355/4885MEN1 1805/4885KMT2A 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.